The Global Fund

Money Moves

Appointing a new executive director amid a funding shortfall

The Global Fund to Fight AIDS, Tuberculosis and Malaria named Mark Dybul as its next executive director on 28 October 2026, returning him to a job he held from 2013 to 2017. He starts a four-year term in early 2027, replacing Peter Sands, who has led the organization since 2018.

Updated 2 hours ago

New Capabilities

Co-funder and first deliverer of lenacapavir

On Nov. 2, the U.S. Food and Drug Administration gave tentative approval to a generic version of lenacapavir made by India's Dr. Reddy's Laboratories. The twice-yearly shot is expected to sell for about $40 per person per year in 120 low- and middle-income countries. It cannot be sold in the U.S.

Updated 5 days ago

New Capabilities

As of August 2026: Co-funds treatment and prevention

In 1995, HIV infected about 3 million people in a single year. In 2022 that number fell to 1.3 million, the fewest since the late 1980s.

Updated Aug 5